KEROS THERAPEUTICS, INC. (KROS) Operating margin 2019–2025
KEROS THERAPEUTICS, INC. (KROS) operating margin by fiscal year — reported operating income divided by reported revenue.
27.7%FY2025 · since FY2019: -105.6% → 27.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 27.7% | +5966.6 pp |
| FY2024 | -5939.0% | +106604.8 pp |
| FY2023 | -112543.7% | — |
| FY2021 | -280.5% | — |
| FY2019 | -105.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice